Biocardia announces helix™ biotherapeutic delivery patent issuance in japan

Sunnyvale, calif., june 08, 2023 (globe newswire) -- biocardia®, inc.  [nasdaq: bcda], a company focused on cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases today announces that the japan patent office has granted patent no: jp7282649b2 titled “radial and transendocardial delivery catheter” with a patent term that will expire on september 30, 2034.
BCDA Ratings Summary
BCDA Quant Ranking